These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1682679)

  • 41. Use of surfactant in pulmonary disorders in full-term infants.
    Sun B
    Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival of newborn infants with severe respiratory failure before and after establishing an extracorporeal membrane oxygenation program.
    Kattan J; González A; Becker P; Faunes M; Estay A; Toso P; Urzúa S; Castillo A; Fabres J
    Pediatr Crit Care Med; 2013 Nov; 14(9):876-83. PubMed ID: 23863822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surfactant metabolism in the neonate.
    Zimmermann LJ; Janssen DJ; Tibboel D; Hamvas A; Carnielli VP
    Biol Neonate; 2005; 87(4):296-307. PubMed ID: 15985752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Venovenous ECMO for Congenital Diaphragmatic Hernia: Role of Ductal Patency and Lung Recruitment.
    Moscatelli A; Pezzato S; Lista G; Petrucci L; Buratti S; Castagnola E; Tuo P
    Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxic respiratory failure in the late preterm infant.
    Dudell GG; Jain L
    Clin Perinatol; 2006 Dec; 33(4):803-30; abstract viii-ix. PubMed ID: 17148006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimally Invasive Surfactant Therapy and Noninvasive Respiratory Support.
    Kribs A
    Clin Perinatol; 2016 Dec; 43(4):755-771. PubMed ID: 27837757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early surfactant for respiratory distress syndrome in premature infants.
    Scopesi F; Parodi A; Natalizia AR; Sannia A; Ramenghi LA
    Acta Biomed; 2013; 84 Suppl 1():12-4. PubMed ID: 24049954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary surfactant dysfunction in congenital diaphragmatic hernia: experimental and clinical findings.
    Valls-i-Soler A; Alfonso LF; Arnaiz A; Alvarez FJ; Tovar JA
    Biol Neonate; 1996; 69(5):318-26. PubMed ID: 8790910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of high frequency oscillatory ventilation (HFOV) for respiratory distress syndrome (RDS).
    Stewart DL; Hilbert T
    J Ky Med Assoc; 1999 Jan; 97(1):17-21. PubMed ID: 9973781
    [No Abstract]   [Full Text] [Related]  

  • 50. [Surfactant replacement--prevention and therapy in respiratory distress syndrome].
    Schimmel MS
    Harefuah; 1992 Apr; 122(7):431-3. PubMed ID: 1592303
    [No Abstract]   [Full Text] [Related]  

  • 51. Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome.
    Moriette G; Paris-Llado J; Walti H; Escande B; Magny JF; Cambonie G; Thiriez G; Cantagrel S; Lacaze-Masmonteil T; Storme L; Blanc T; Liet JM; André C; Salanave B; Bréart G
    Pediatrics; 2001 Feb; 107(2):363-72. PubMed ID: 11158471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Score for Neonatal Acute Physiology-II Predicts Outcome in Congenital Diaphragmatic Hernia Patients.
    Snoek KG; Capolupo I; Morini F; van Rosmalen J; Greenough A; van Heijst A; Reiss IK; IJsselstijn H; Tibboel D;
    Pediatr Crit Care Med; 2016 Jun; 17(6):540-6. PubMed ID: 27104681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
    Salvo V; Zimmermann LJ; Gavilanes AW; Barberi I; Ricotti A; Abella R; Frigiola A; Giamberti A; Florio P; Tagliabue P; Tina LG; Nigro F; Temporini F; Gazzolo D
    Pediatr Crit Care Med; 2012 Jan; 13(1):72-9. PubMed ID: 21499177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond.
    Sürmeli-Onay O; Korkmaz A; Yiğit S; Yurdakök M
    Turk J Pediatr; 2012; 54(3):239-46. PubMed ID: 23094533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. American Academy of Pediatrics Committee on Fetus and Newborn: Surfactant replacement therapy for respiratory distress syndrome.
    Pediatrics; 1991 Jun; 87(6):946-7. PubMed ID: 2034505
    [No Abstract]   [Full Text] [Related]  

  • 57. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surfactant and mechanical ventilation.
    Lista G; Castoldi F; Bianchi S; Cavigioli F
    Acta Biomed; 2012; 83 Suppl 1():21-3. PubMed ID: 23029872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current experience with liquid ventilation.
    Hirschl RB
    Paediatr Respir Rev; 2004; 5 Suppl A():S339-45. PubMed ID: 14980292
    [No Abstract]   [Full Text] [Related]  

  • 60. [CPAP as a method of primary respiratory support in premature infants with acute respiratory distress syndrome].
    Mazmanyan PA
    Anesteziol Reanimatol; 2013; (1):31-4. PubMed ID: 23808250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.